The Gilead Sciences, Inc. (GILD) revenue growth is 3.3%, which is lower than the industry median of 5.6% and the 5-year historical average of 4.6%.
The Gilead Sciences, Inc. (GILD) operating income growth is 1.5%, compared to the industry median of 17.2% and the 5-year historical average of 25.7%.
The Gilead Sciences, Inc. (GILD) EPS growth is (97.9%), compared to the industry median of (21.3%) and the 5-year historical average of 344.9%.
The Gilead Sciences, Inc. (GILD) Free Cash Flow growth is 20.1%, compared to the industry median of 18.1% and the 5-year historical average of 2.7%.